Pricing

Advaxis, Inc. (ADXS)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Ken Berlin
Employees:
20
9 DEER PARK DRIVE, SUITE K-1, MONMOUTH JUNCTION, NJ, 08852
732 545 1590

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • ADVAXIS INC (NEW) COM STK (DE)
  • ADVAXIS INC (NEW) COM STK (DE)
  • Advaxis Inc.
  • Advaxis Inc.
Stock Split History
DateRatio
2013-07-15 1:125
2019-03-29 1:15
Advaxis, Inc. focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available